close

BioScrip, Inc., a specialty pharmaceutical healthcare organization, provides medications and management solutions for chronic and other healthcare conditions in the United States. It operates through two segments, Specialty Pharmaceutical Services (Specialty Services) and Pharmacy Benefit Management Services (PBM Services). The Specialty Services segment offers local prescription fulfillment, distribution, and patient management services through its community pharmacy network where it stocks medications and provide support and counseling to patients at the point of sale or through delivery; national specialty drug fulfillment, distribution, and patient management services to patients, health plans, manufacturers, and physicians through its mail order facilities; and drug infusion services through its infusion pharmacies for patients requiring infused medications in the home, a physician's office, or ambulatory infusion site. As of December 31, 2008, it owned and operated 39 specialty pharmacies comprising community, mail order, and infusion pharmacies. This segment primarily focus on serving patient populations with chronic health conditions, including psoriasis; growth hormones, thyroid cancer; sickle cell anemia/thalassemia, myelodysplastic syndromes, and bleeding disorders/hemophilia; multiple sclerosis and neuropathies; in office infusions and oral oncolytics; rheumatoid arthritis, osteoarthritis, and osteoporosis; solid organ and bone marrow transplant; and HIV/AIDS, hepatitis, and respiratory syncytial virus. The Specialty Services segment provides PBM services to employers, managed care organizations, third party administrators, and other plan sponsors. This segment offers clinical, formulary and benefit design, drug usage evaluation, pharmacy data, and pharmacy dispensing facility services, as well as discount prescription card programs. The company was founded in 1993 and is based in Elmsford, New York.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	6.71
Volume	310577
Volume Avg	305640
52 Week High	7.85
52 Week Low	4.06
PE	48.64
PE (group average)	39
EPS Year	0.14
EPS change Q/Q	1000%
EPS change Q/Q Yr ago	1000%
EPS change Q/Q next Q est	1000%
EPS change Y/Y	-1000%
REV change Q/Q	2.09%
REV change Q/Q Yr ago	31.85%
EPS next Q est	0.04
EPS next Y est	0.49
Divident Annual	0.00
Dividend Yield	0%